Brief: Halozyme Reiterates 2024 Financial Guidance And Raises 2025 And Multi-Year Financial Guidance

Halozyme Therapeutics

08/01/2025 12:17

Jan 8 (Reuters) - Halozyme Therapeutics Inc  HALO.O :
    * HALOZYME REITERATES 2024 FINANCIAL GUIDANCE AND RAISES
2025 AND
MULTI-YEAR FINANCIAL GUIDANCE
    * HALOZYME THERAPEUTICS INC: ANNOUNCES NEW $250 MILLION
ACCELERATED SHARE REPURCHASE
    * HALOZYME THERAPEUTICS: RAISES 2025 FINANCIAL GUIDANCE
RANGES FOR
TOTAL REVENUE TO $1,150 - $1,225 MILLION
    * HALOZYME THERAPEUTICS INC: OUTLOOK 2025 ADJUSTED EPS $4.95
TO
$5.35

Source text:  ID:nPncbv3GDa 
Further company coverage:  HALO.O 

 ((Reuters.Brief@thomsonreuters.com))